Skip to content
Gilead Sciences logo

Current Assets

Gilead Sciences·Balance Sheet Statement·14 metrics

Breakdown

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Raw materials$1.3B$1.3B$1.3B$1.2B$1.3B$1.4B$1.4B$1.4B
Work in process$803M$684M$847M$1.1B$1B$1.3B$1.3B$1.3B
Inventories$1.4B$1.6B$1.9B$2B$2.1B$2.6B$2.6B$2.4B

Metrics

Accounts receivable, net

View metric

Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)

View metric

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

View metric

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

View metric

Cash and cash equivalents

View metric

Finished goods

View metric

Short- term Investments

View metric

Derivative Assets - Fair Value

View metric

Raw materials

View metric

Work in process

View metric

Inventories

View metric

Prepaid expenses and other current assets

View metric

Short-term investments

View metric

Total current assets

View metric